Matches in Wikidata for { <http://www.wikidata.org/entity/Q93210289> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q93210289 description "article scientifique publié en 2020" @default.
- Q93210289 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93210289 description "scientific article published on 01 April 2020" @default.
- Q93210289 description "wetenschappelijk artikel" @default.
- Q93210289 description "наукова стаття, опублікована 1 квітня 2020" @default.
- Q93210289 name "152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents" @default.
- Q93210289 name "152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents" @default.
- Q93210289 type Item @default.
- Q93210289 label "152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents" @default.
- Q93210289 label "152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents" @default.
- Q93210289 prefLabel "152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents" @default.
- Q93210289 prefLabel "152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents" @default.
- Q93210289 P1433 Q93210289-426505F1-B119-4C50-B2E5-1A0D5B38EFA5 @default.
- Q93210289 P1476 Q93210289-AF50F051-F0F8-43E4-AEAD-0ADB3B8762F1 @default.
- Q93210289 P2093 Q93210289-29B4A32A-71AB-4C68-B965-C2E6F6A33EF9 @default.
- Q93210289 P2093 Q93210289-2CE4FFCF-93D0-42D4-9491-8BB356912FF7 @default.
- Q93210289 P2093 Q93210289-4FF54F31-3568-4286-8C62-37F133909FE7 @default.
- Q93210289 P2093 Q93210289-56B14051-D18A-436B-9AB1-90F7A58452D2 @default.
- Q93210289 P2093 Q93210289-66430CF0-273B-4DEC-B7A1-26FB2EE917BB @default.
- Q93210289 P2093 Q93210289-6AE7947A-AB2C-4313-8C4A-A40869527250 @default.
- Q93210289 P2093 Q93210289-95D59782-A916-456D-BBF2-42FEF733F9BE @default.
- Q93210289 P2093 Q93210289-BAEBEF91-F5C5-465A-A346-B082FE4638A4 @default.
- Q93210289 P2093 Q93210289-C1A3E089-66B1-4BC4-88F3-AD6CC7275B7F @default.
- Q93210289 P304 Q93210289-F697B126-95F4-4408-A3A7-C59BBAD5267D @default.
- Q93210289 P31 Q93210289-B6C4C3E7-2E54-41C4-B477-295F636C43F1 @default.
- Q93210289 P356 Q93210289-D083FF14-75C2-46DD-8D82-B7D2E5BE0B7D @default.
- Q93210289 P433 Q93210289-BE22D97C-BC5E-4601-B271-8065E4BDDF9D @default.
- Q93210289 P478 Q93210289-E472337F-2716-44AA-9F15-823B404D23A8 @default.
- Q93210289 P577 Q93210289-701B3B55-385F-4C48-B911-BBC8E9FA64C8 @default.
- Q93210289 P921 Q93210289-64524AEC-711B-42EA-BE37-A281D2A1869D @default.
- Q93210289 P356 S1092852920000681 @default.
- Q93210289 P1433 Q15750260 @default.
- Q93210289 P1476 "152 Development of Deutetrabenazine as a Potential New Non-Antipsychotic Treatment for Tourette Syndrome in Children and Adolescents" @default.
- Q93210289 P2093 "Barbara Coffey" @default.
- Q93210289 P2093 "Barry J Gertz" @default.
- Q93210289 P2093 "Daniel O Claassen" @default.
- Q93210289 P2093 "David Stamler" @default.
- Q93210289 P2093 "Elisabeth A Garofalo" @default.
- Q93210289 P2093 "Joseph Jankovic" @default.
- Q93210289 P2093 "Juha-Matti Savola" @default.
- Q93210289 P2093 "Maria Wieman" @default.
- Q93210289 P2093 "Mark Forrest Gordon" @default.
- Q93210289 P304 "297" @default.
- Q93210289 P31 Q13442814 @default.
- Q93210289 P356 "10.1017/S1092852920000681" @default.
- Q93210289 P433 "2" @default.
- Q93210289 P478 "25" @default.
- Q93210289 P577 "2020-04-01T00:00:00Z" @default.
- Q93210289 P921 Q191779 @default.